40% of clinical trial sites fail to enroll a single patient — and the cost of poor site selection is staggering. In this post, we explore why trials still fall short in 2025, what it’s really costing sponsors, and how smarter strategies can change everything.

CROs, sponsors, and clinical teams can streamline site selection using smarter tools, global networks, and real-world experience. If you're tired of spreadsheets and chasing down sites, this one's for you.